Koenig Sheldon L., President and CEO of Esperion Therapeutics, Inc. ($ESPR), sold shares on the open market four times in the last 365 days, totaling about $310,000. His most recent sale occurred on December 17, 2025. These sales rank 7,475th among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. Koenig has made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | S | Common Stock | 25578 | $2.72 | 2,172,699.0000 | 239,063,437 | 1.16% | 0.01% |
| March 13, 2026 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | A | Common Stock | 723760 | $0.00 | 2,198,277.0000 | 239,063,437 | 49.08% | 0.30% |
| March 13, 2026 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | A | Stock Option (right to buy) | 647460 | $0.00 | 647,460.0000 | 239,063,437 | 9999.99% | 0.27% |
| Dec. 17, 2025 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | S | Common Stock | 48244 | $3.67 | 1,470,587.0000 | 239,063,437 | 3.18% | 0.02% |
| Sept. 17, 2025 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | S | Common Stock | 28427 | $2.79 | 1,518,831.0000 | 197,848,886 | 1.84% | 0.01% |
| June 17, 2025 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | S | Common Stock | 30474 | $1.11 | 1,541,488.0000 | 197,848,886 | 1.94% | 0.02% |
| March 18, 2025 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | S | Common Stock | 13047 | $1.50 | 1,571,962.0000 | 197,848,886 | 0.82% | 0.01% |
| March 14, 2025 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | A | Stock Option (right to buy | 753000 | $0.00 | 753,000.0000 | 197,848,886 | 9999.99% | 0.38% |
| March 14, 2025 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | A | Common Stock | 840000 | $0.00 | 1,585,009.0000 | 197,848,886 | 112.75% | 0.42% |
| Dec. 17, 2024 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | S | Common Stock | 12447 | $2.47 | 739,819.0000 | 0 | 1.65% | 0.00% |
| Sept. 17, 2024 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | S | Common Stock | 14550 | $1.80 | 752,266.0000 | 0 | 1.90% | 0.00% |
| March 14, 2024 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | A | Common Stock | 454000 | $0.00 | 766,816.0000 | 0 | 145.13% | 0.00% |
| March 14, 2024 | Esperion Therapeutics, Inc. | $ESPR | Koenig Sheldon L. | President and CEO | A | Stock Option (right to buy) | 642000 | $0.00 | 642,000.0000 | 0 | 9999.99% | 0.00% |